Paroxetine Tablet, Film Coated, Extended Release
Product Images NDC 68180-647

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Paroxetine (NDC 68180-647). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Lupin Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

66042161 13e0 4385 98a7 3e90c8382685 01

Chemical structure diagram of PAROXETINE including its hydrochloride salt form with half a molecule of water (hydrate). The diagram shows the molecular arrangement of atoms and bonds typical for the active ingredient Paroxetine.*

FDA Label Image

66042161 13e0 4385 98a7 3e90c8382685 02

A scatter plot depicting the fold change and 90% confidence intervals for pharmacokinetic parameters Cmax and AUC of interacting drugs Pimozide, Desipramine, Propranolol, Digoxin, and Phenytoin relative to reference values. The x-axis represents the fold change on a logarithmic scale from 0.1 to 10, showing comparative pharmacokinetic impacts of these drugs.*

FDA Label Image

66042161 13e0 4385 98a7 3e90c8382685 03

A chart depicting the fold change and 90% confidence interval (CI) in pharmacokinetic parameters Cmax and AUC relative to a reference, for various interacting drugs including Cimetidine, Phenobarbital, Phenytoin, Digoxin, and Diazepam. The x-axis shows change relative to reference values.*

FDA Label Image

66042161 13e0 4385 98a7 3e90c8382685 04

A chart showing pharmacokinetic (PK) fold changes and 90% confidence intervals (CI) for Paroxetine in different population groups, including various levels of renal impairment, hepatic impairment, age categories over 65 years with different doses, and gender (males). The horizontal axis represents change relative to reference, with measures such as Cmax, AUC, and Cmin plotted for each group.*

FDA Label Image

66042161 13e0 4385 98a7 3e90c8382685 05

Packaging label for Paroxetine Extended-Release Tablets USP, 12.5 mg, film-coated extended-release tablets. The label indicates a quantity of 30 tablets, manufactured by Lupin Pharmaceuticals, Inc. and Lupin Limited, with storage and usage notes. The label includes the NDC 68180-647-06 and specifies Rx only.*

FDA Label Image

66042161 13e0 4385 98a7 3e90c8382685 06

Label for Paroxetine Extended-Release Tablets USP 25 mg, film-coated extended-release oral tablets. The label shows a 30 tablet count from Lupin Pharmaceuticals, Inc., with directions for pharmacist dispensing and storage instructions. This product is manufactured by Lupin Limited in India for Lupin Pharmaceuticals, Inc. in the United States.*

FDA Label Image

66042161 13e0 4385 98a7 3e90c8382685 07

Packaging label for Paroxetine Extended-Release Tablets USP 37.5 mg by Lupin Pharmaceuticals, Inc. The label specifies 30 film-coated, extended-release tablets, with storage instructions and a barcode. Manufactured by Lupin Limited, India, and labeled for prescription use only.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.